Phenominer Database Results (10 results)

 
 
How to display a graph
Strain Phenotype Conditions Study Experiment Name Sex Age # of Animals Value Units SEM SD Method Method Duration Post Insult Time Value Method Notes Experiment Notes Record ID Study ID
DA.PVG.1AV1-(D4Rat155-Spr) serum orosomucoid 1 level type II collagen (500 ug) and Freund's incomplete adjuvant (100 ul) Backdahl L, et al., Arthritis Rheum 2003 Feb;48(2):551-9. orosomucoid 1 amount both 120.0 days-180.0 days 14 660.0 mg/l radial immunodiffusion assay 0.0 radial immunodiffusion assay blood alpha-1-acid glycoprotein amount 69759 1162
DA.PVG.1AV1-(D4Rat155-Spr) serum orosomucoid 1 level pristane (150 ul) Backdahl L, et al., Arthritis Rheum 2003 Feb;48(2):551-9. orosomucoid 1 amount both 120.0 days-180.0 days 24 1060.0 mg/l radial immunodiffusion assay 0.0 radial immunodiffusion assay blood alpha-1-acid glycoprotein amount 69766 1162
DA.PVG.1AV1-(D4Rat155-Spr) post-insult time to onset of experimental arthritis pristane (150 ul) Backdahl L, et al., Arthritis Rheum 2003 Feb;48(2):551-9. joint integrity trait both 120.0 days-200.0 days 24 12.5 d 0.5 2.45 in vivo visual assessment 0.0 69787 1162
DA.PVG.1AV1-(D4Rat155-Spr) maximum body weight loss to initial body weight ratio type II collagen (500 ug) and Freund's incomplete adjuvant (100 ul) Backdahl L, et al., Arthritis Rheum 2003 Feb;48(2):551-9. body mass both 120.0 days-200.0 days 14 12.5 % 0.9 3.37 body weighing method 0.0 69800 1162
DA.PVG.1AV1-(D4Rat155-Spr) post-insult time to onset of experimental arthritis Freund's incomplete adjuvant (200 ul) Ribbhammar U, et al., Hum Mol Genet 2003 Sep 1;12(17):2087-96. joint integrity trait both  days 12 13.7 d 0.43 1.5 in vivo visual assessment 0.0 70198 1301
DA.PVG.1AV1-(D4Rat155-Spr) percentage of study population developing experimental arthritis during a period of time pristane (150 ul) Backdahl L, et al., Arthritis Rheum 2003 Feb;48(2):551-9. joint integrity trait both 120.0 days-200.0 days 24 100.0 % in vivo visual assessment 0.0 69719 1162
DA.PVG.1AV1-(D4Rat155-Spr) maximum body weight loss to initial body weight ratio pristane (150 ul) Backdahl L, et al., Arthritis Rheum 2003 Feb;48(2):551-9. body mass both 120.0 days-200.0 days 24 10.6 % 1.1 5.39 body weighing method 0.0 69806 1162
DA.PVG.1AV1-(D4Rat155-Spr) post-insult time to onset of experimental arthritis type II collagen (500 ug) and Freund's incomplete adjuvant (100 ul) Backdahl L, et al., Arthritis Rheum 2003 Feb;48(2):551-9. joint integrity trait both 120.0 days-200.0 days 14 14.3 d 0.3 1.12 in vivo visual assessment 0.0 69780 1162
DA.PVG.1AV1-(D4Rat155-Spr) percentage of study population developing experimental arthritis during a period of time type II collagen (500 ug) and Freund's incomplete adjuvant (100 ul) Backdahl L, et al., Arthritis Rheum 2003 Feb;48(2):551-9. joint integrity trait both 120.0 days-200.0 days 14 100.0 % in vivo visual assessment 0.0 69712 1162
DA.PVG.1AV1-(D4Rat155-Spr) percentage of study population developing experimental arthritis during a period of time Freund's incomplete adjuvant (200 ul) Ribbhammar U, et al., Hum Mol Genet 2003 Sep 1;12(17):2087-96. joint integrity trait both  days 12 25.0 % in vivo visual assessment 0.0 70197 1301